The New York-based pharmaceutical giant said it pulled its applications for a combination of its immunotherapy drugs Opdivo and Yervoy after recent discussions with the FDA.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA promises 'threat' to vaping if companies continue marketing to youthFDA issues threat to vaping if companies continue marketing to youth
Lire la suite »
Promising new drug for aggressive stage IV breast cancer encounters setbackPromising new drug for aggressive stage IV breast cancer delayed by FDA.
Lire la suite »
FDA chief threatens to take e-cigarettes off the marketFDA commissioner made his most direct threat yet against e-cigarette companies, saying they face an “existential threat” if they don’t stop marketing to youth.
Lire la suite »